Home / Bio-technology / Global Human Microbiome Based Drugs and Diagnostics Market Size, Status and Forecast -2025

Global Human Microbiome Based Drugs and Diagnostics Market Size, Status and Forecast -2025

  • Id : RNR-228239
  • Category : Bio-technology
  • Publish Date : 2018
  • Pages : 91
  • Format : PDF
License Type

Description
The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.
Rising cases of chronic diseases such as diabetes, disorders at early stage and the ability of the drugs to diagnose them and increased awareness among people to maintain healthy lifestyle is driving the growth of this market.

In 2017, the global Human Microbiome Based Drugs and Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Human Microbiome Based Drugs and Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Microbiome Based Drugs and Diagnostics development in United States, Europe and China.

The key players covered in this study

    Second Genome Inc.

    Enterome Bioscience

    Yakult

    DuPont

    Vedanta BioSciences

    Metabiomics Corporation

    ViThera Pharmaceuticals

    MicroBiome Therapeutics LLC

    Osel

    Merck

Market segment by Type, the product can be split into

    Therapeutics

    Diagnostics

Market segment by Application, split into

    Clinical Research Institutes

    Hospital

    Surgical Centers

    Others

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global Human Microbiome Based Drugs and Diagnostics status, future forecast, growth opportunity, key market and key players.

    To present the Human Microbiome Based Drugs and Diagnostics development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Microbiome Based Drugs and Diagnostics are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.